semaglutide podcast Stephan Guyenet, PhD: GLP-1, Semaglutide, and the Big Future of Weight Loss Therapies What's Up, Doc? | Healthcare

doi:10.1038/s41598-018-37215-0 92

Good candidates for GLP-1 weight loss therapy generally have a BMI of 30 or higher, or 27 or higher with weight-related health conditions like type 2 diabetes or hypertension

By reducing the production of prostaglandins, aspirin helps relieve symptoms like headaches, muscle pain, and joint pain

J Diabetes Complicat 26:352358 Hsu Y, Tseng Y, Lo Y (2013) Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth

In practice, many people manage better by setting clear expectations for this transition period

Easing GLP-1 Side Effects: Informed Relief for Nausea and Constipation Executive Summary Executive Summary Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized the treatment of type 2 diabetes and obesity and are now among the most prescribed medications for use in adults with these conditions [1]